SE8304887L - Forfarande for uppspjelkning av en racemisk modifikation av beta-adrenergiska aryl- eller hetaryloxipropanolaminer - Google Patents

Forfarande for uppspjelkning av en racemisk modifikation av beta-adrenergiska aryl- eller hetaryloxipropanolaminer

Info

Publication number
SE8304887L
SE8304887L SE8304887A SE8304887A SE8304887L SE 8304887 L SE8304887 L SE 8304887L SE 8304887 A SE8304887 A SE 8304887A SE 8304887 A SE8304887 A SE 8304887A SE 8304887 L SE8304887 L SE 8304887L
Authority
SE
Sweden
Prior art keywords
racemic modification
beta
aryl
hetaryloxypropanolamines
addrenergic
Prior art date
Application number
SE8304887A
Other languages
English (en)
Other versions
SE8304887D0 (sv
SE452608B (sv
Inventor
R D Dennis
T M Dolak
W E Kreighbaum
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8304887D0 publication Critical patent/SE8304887D0/sv
Publication of SE8304887L publication Critical patent/SE8304887L/sv
Publication of SE452608B publication Critical patent/SE452608B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE8304887A 1982-09-13 1983-09-12 Forfarande for uppspjelkning av en racemisk modifikation av beta-adrenergiska aryl- eller hetaryloxipropanolaminer SE452608B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/417,794 US4463176A (en) 1982-09-13 1982-09-13 Process for resolution of optical isomers

Publications (3)

Publication Number Publication Date
SE8304887D0 SE8304887D0 (sv) 1983-09-12
SE8304887L true SE8304887L (sv) 1984-03-14
SE452608B SE452608B (sv) 1987-12-07

Family

ID=23655420

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8304887A SE452608B (sv) 1982-09-13 1983-09-12 Forfarande for uppspjelkning av en racemisk modifikation av beta-adrenergiska aryl- eller hetaryloxipropanolaminer
SE8602724A SE8602724D0 (sv) 1982-09-13 1986-06-18 Karbamidmellanprodukter och forfarande for framstellning derav

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8602724A SE8602724D0 (sv) 1982-09-13 1986-06-18 Karbamidmellanprodukter och forfarande for framstellning derav

Country Status (29)

Country Link
US (1) US4463176A (sv)
JP (2) JPS5980616A (sv)
KR (1) KR890000616B1 (sv)
AT (1) AT385032B (sv)
AU (1) AU573535B2 (sv)
BE (1) BE897737A (sv)
CA (1) CA1250290A (sv)
CH (1) CH660732A5 (sv)
CY (1) CY1543A (sv)
DE (1) DE3333025A1 (sv)
DK (2) DK172720B1 (sv)
ES (1) ES525543A0 (sv)
FI (1) FI83767C (sv)
FR (1) FR2540490B1 (sv)
GB (2) GB2127020B (sv)
GR (1) GR81546B (sv)
HK (1) HK97990A (sv)
HU (1) HU193183B (sv)
IE (1) IE55650B1 (sv)
IL (1) IL69708A (sv)
IT (1) IT1170213B (sv)
LU (1) LU84998A1 (sv)
NL (1) NL8303154A (sv)
NO (1) NO159267C (sv)
NZ (1) NZ205554A (sv)
PT (1) PT77331B (sv)
SE (2) SE452608B (sv)
YU (1) YU43327B (sv)
ZA (1) ZA836795B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849527A (en) * 1982-09-13 1989-07-18 Bristol-Myers Company Process for resolution of optical isomers
IT1163107B (it) * 1983-02-15 1987-04-08 Simes Composizioni farmaceutiche e loro uso nel trattamento del glaucoma
US5364872A (en) * 1984-04-16 1994-11-15 Yamanouchi Pharmaceutical Co., Ltd. Dihydropyridine-3,5-dicarboxylic acid ester derivatives
US5039801A (en) * 1985-12-20 1991-08-13 The United States Of America As Represented By The Department Of Health & Human Services Thermal fragmentation of methylbenzylurea disastereomers or secondary amines and preparation of optically active secondary amines
US4797498A (en) * 1986-07-18 1989-01-10 Pennwalt Corporation Flavonoxypropanolamines and esters of flavonoxypropanolamines as antiarrhythmic agents
WO1988007044A1 (en) * 1987-03-17 1988-09-22 Insite Vision, Inc. Timolol derivatives
US4889941A (en) * 1987-04-23 1989-12-26 Fisons Corporation Synthetic flavonoids as inhibitors of leukotrienes and 5-lipoxygenase
US4806660A (en) * 1987-11-06 1989-02-21 Pennwalt Corporation Aurone oxypropanolamines
JP2801768B2 (ja) * 1990-11-17 1998-09-21 日東電工株式会社 新規な光学活性メトプロロール・酒石酸誘導体塩及びその製法、並びにこの塩を用いる光学活性メトプロロールの製法
US5082970A (en) * 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
ES2065278B1 (es) * 1993-06-24 1995-09-01 Medichem Sa Procedimiento de obtencion enantioselectivo del levobunolol.
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
KR100332399B1 (ko) * 1999-02-22 2002-04-13 김경호 메토프롤롤 라세미체로부터 메토프롤롤 에난티오머의 제조방법
BE1012622A3 (fr) 1999-04-21 2001-01-09 Solvay Procede pour la separation d'enantiomeres et reactif enantiopur.
US7138538B2 (en) * 2000-04-14 2006-11-21 Solvay (Societe Anonyme) Process for the separation of enantiomers and enantiopure reagent
CA2495962A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
KR101695582B1 (ko) 2013-04-17 2017-01-13 화이자 인코포레이티드 심혈관 질환을 치료하기 위한 n-피페리딘-3-일벤즈아미드 유도체
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US234595A (en) * 1880-11-16 Juan f
GB1211589A (en) * 1968-08-06 1970-11-11 Ici Ltd Enantiomer isolation process
BE786963A (fr) * 1971-07-30 1973-01-29 Degussa Procede pour le dedoublement racemique de d,1-phenylpropanolamine
US4234595A (en) * 1977-07-13 1980-11-18 Mead Johnson & Company 3-Indolyl-tertiary butylaminopropanols
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
JPS5770884A (en) * 1980-10-21 1982-05-01 Kyowa Hakko Kogyo Co Ltd Novel piperidine derivative and its preparation
FI76551C (sv) * 1980-11-06 1988-11-10 Sandoz Ag Förfarande för framställning av nya terapeutiskt användbara 3-aminopro poxifenylderivat

Also Published As

Publication number Publication date
NL8303154A (nl) 1984-04-02
PT77331A (en) 1983-10-01
BE897737A (fr) 1984-03-12
GR81546B (sv) 1984-12-11
HK97990A (en) 1990-11-30
GB8324536D0 (en) 1983-10-12
SE8602724L (sv) 1986-06-18
US4463176A (en) 1984-07-31
ZA836795B (en) 1984-04-25
ES8504104A1 (es) 1985-04-16
IE832134L (en) 1984-03-13
AT385032B (de) 1988-02-10
DK106897A (da) 1997-09-17
FR2540490A1 (fr) 1984-08-10
KR890000616B1 (ko) 1989-03-22
GB2169294A (en) 1986-07-09
ATA326383A (de) 1987-07-15
JP2759184B2 (ja) 1998-05-28
DK416483A (da) 1984-03-14
NO159267B (no) 1988-09-05
AU1908183A (en) 1984-03-22
GB8604515D0 (en) 1986-04-03
DE3333025C2 (sv) 1992-01-23
YU43327B (en) 1989-06-30
JPH0414086B2 (sv) 1992-03-11
SE8304887D0 (sv) 1983-09-12
NO159267C (no) 1988-12-14
FR2540490B1 (fr) 1986-09-05
DE3333025A1 (de) 1984-03-29
CH660732A5 (fr) 1987-06-15
IT8322852A0 (it) 1983-09-12
YU184683A (en) 1986-02-28
IT1170213B (it) 1987-06-03
KR840005998A (ko) 1984-11-21
DK416483D0 (da) 1983-09-13
JPS5980616A (ja) 1984-05-10
CA1250290A (en) 1989-02-21
GB2127020B (en) 1987-05-07
ES525543A0 (es) 1985-04-16
CY1543A (en) 1991-03-22
JPH0859597A (ja) 1996-03-05
DK172732B1 (da) 1999-06-21
IL69708A (en) 1987-02-27
IL69708A0 (en) 1983-12-30
FI833270A0 (fi) 1983-09-13
HU193183B (en) 1987-08-28
AU573535B2 (en) 1988-06-16
FI83767C (sv) 1991-08-26
PT77331B (en) 1986-08-28
DK172720B1 (da) 1999-06-14
SE8602724D0 (sv) 1986-06-18
LU84998A1 (fr) 1984-04-24
IE55650B1 (en) 1990-12-05
NO833254L (no) 1984-03-14
GB2127020A (en) 1984-04-04
GB2169294B (en) 1987-05-13
SE452608B (sv) 1987-12-07
FI833270A (fi) 1984-03-14
NZ205554A (en) 1987-09-30
FI83767B (fi) 1991-05-15

Similar Documents

Publication Publication Date Title
SE8304887L (sv) Forfarande for uppspjelkning av en racemisk modifikation av beta-adrenergiska aryl- eller hetaryloxipropanolaminer
FI941766A (sv) 1H-indol-3-ättikssyrahydrazid-inhibitorer av sPLA2
DE69327567D1 (de) Verfahren zur Herstellung von Alanylglutamin
DE3883456D1 (de) Verfahren zur Herstellung von substituierten Indolinonderivaten.
CO4700282A1 (es) Compuestos
HUP9900344A2 (hu) Eljárás optikailag aktív indolin-2-karbonsavnak vagy származékának előállítására
DK164661C (da) Analogifremgangsmaade til fremstilling af aminoalkadien-derivater
DE3467574D1 (en) Process for the optical resolution of a mixture of the enantiomers of trans-3-((4-methoxyphenoxy)-methyl)-1-methyl-4-phenylpiperidine
DE69809888D1 (de) Verfahren zur Herstellung von alpha-Aminoketonen
TWI255812B (en) A process for the preparation of r-(+)-6-carboxamido-3-n-methylamino-1,2,3,4-tetrahydrocarbazole
DK157539C (da) Fremgangsmaade til fremstilling af acemetacin
DE3462489D1 (en) Process for the enantioselective preparation of acyclic alpha-alkylated alpha-aminecarboxylic acids
HUT34435A (en) Process for preparing derivatives of gamma-allenyl-gamma-amino-butyric acid
FI834637A (fi) Foerfarande foer oeverfoering av enantiomerer i racemisk form.
FI875602A0 (fi) Optiskt aktivt tetrahydro-2-furanonderivat saosom miksobicid.
DE2963107D1 (en) Process for preparing amino acids and esters
ES8400741A1 (es) Procedimiento para la preparacion de un derivado de dibenzoxepinona.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8304887-6

Format of ref document f/p: F

NUG Patent has lapsed